Male Hormonal Contraceptive Development-ACY-5

• Status: Completed
• Trial end date: 2006-04-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this research study is to help in the development of male contraception (birth control).

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Washington
• Collaborators: CONRAD; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
• Treatments: Acyline; Contraceptive Agents; Medroxyprogesterone; Medroxyprogesterone Acetate; Methyltestosterone; Testosterone; Testosterone 17 beta-cypionate; Testosterone enanthate; Testosterone undecanoate

Criteria

Inclusion Criteria:

• Males between 18-55

• In good general health

• With normal sperm counts

• Willing to use an acceptable form of contraception

Exclusion Criteria:

• Men in poor health

• Significant chronic or acute medical illness

• Skin conditions that might interfere with or be exacerbated by testosterone gel

• Known history of alcohol, illicit drug or anabolic steroid abuse

• Abnormal reproductive function

• Participation in a long-term male contraceptive study within past three months